ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Impact of Vaccination, Prior Infection, and Therapy on Delta and Omicron Variants
This article has 4 authors:Reviewed by ScreenIT
-
Risk factors and preventive interventions for post Covid-19 condition: systematic review
This article has 5 authors:Reviewed by ScreenIT
-
Vaccine effectiveness with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine against reported SARS-CoV-2 Delta and Omicron infection among adolescents, Norway, August 2021 to January 2022
This article has 10 authors:Reviewed by ScreenIT
-
Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics’ impact
This article has 2 authors:Reviewed by ScreenIT
-
A Computational Pipeline to Identify and Characterize Binding Sites and Interacting Chemotypes in SARS-CoV-2
This article has 6 authors:Reviewed by ScreenIT
-
Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq
This article has 36 authors:This article has been curated by 1 group: -
Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19
This article has 17 authors:Reviewed by Review Commons, ScreenIT
-
Production of anti-spike antibodies in response to COVID vaccine in lymphoma patients
This article has 17 authors:Reviewed by ScreenIT
-
The modified COVID‐19 Yorkshire Rehabilitation Scale (C19‐YRSm) patient‐reported outcome measure for Long Covid or Post‐COVID‐19 syndrome
This article has 11 authors:Reviewed by ScreenIT
-
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study
This article has 6 authors:Reviewed by ScreenIT